LungLife AI, Inc. Sustainability Profile
LungLife AI, Inc., headquartered in the United States, is a pioneering company in the healthcare technology sector, specialising in advanced diagnostic solutions for lung cancer. Founded in 2018, LungLife AI has made significant strides in leveraging artificial intelligence to enhance the accuracy and efficiency of lung cancer detection, positioning itself as a leader in the oncology diagnostics market. The company’s flagship product, the LungLife AI platform, utilises cutting-edge machine learning algorithms to analyse patient data, providing clinicians with actionable insights that improve patient outcomes. This innovative approach not only streamlines the diagnostic process but also sets LungLife AI apart from traditional methods. With a commitment to transforming lung cancer care, LungLife AI continues to achieve notable milestones, solidifying its reputation as a key player in the fight against this prevalent disease.
DitchCarbon Score
How does LungLife AI, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
LungLife AI, Inc.'s score of 25 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
LungLife AI, Inc.'s reported carbon emissions
In 2022, LungLife AI, Inc. reported total carbon emissions of approximately 661,200 kg CO2e, all of which fall under Scope 3 emissions. This indicates that the company has not disclosed any data related to Scope 1 or Scope 2 emissions. Currently, LungLife AI, Inc. does not have any publicly stated reduction targets or commitments, nor does it participate in initiatives such as the Science Based Targets initiative (SBTi) or similar climate pledges. The absence of specific reduction initiatives suggests that the company may be in the early stages of developing a comprehensive climate strategy. As a company headquartered in the US, LungLife AI, Inc. is positioned within an industry increasingly focused on sustainability and carbon footprint reduction. However, without clear targets or commitments, its future climate impact remains uncertain.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | - |
| Scope 2 | - |
| Scope 3 | 661,200 |
How Carbon Intensive is LungLife AI, Inc.'s Industry?
How Carbon Intensive is LungLife AI, Inc.'s Location?
LungLife AI, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
LungLife AI, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
